Entity
  • Calluna Pharma

    Created in 2024
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    1,121
  • Activities

  • Technologies

  • Entity types

  • Location

    Dehns, Forskningsparken Aksjeselskap, Gaustadalléen 21, 0349 Oslo, Norway

    Oslo

    Norway

  • Employees

    Scale: 11-50

    Estimated: 12

  • Engaged corporates

    0
    0 0
  • Added in Motherbase

    9 months ago
Description
  • Value proposition

    Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source.

    Our innovative therapeutic approach targets upstream amplifiers of disease offering potential treatments across a diverse array of therapeutic indications. Calluna Pharma is a clinical stage biotech company driven by a commitment to improve patient outcomes in diseases where existing treatments are sub-optimal.

    We believe in the power of immunology to push boundaries, challenge the status quo, and develop therapies that will make a real difference for people living with serious diseases.

  • Calluna Pharma | Reimagining immunology

    Join Calluna Pharma to transform therapeutics for inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, we can revolutionize patient care.

  • https://www.callunapharma.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Loading...
Loading...
Social network dynamics